KCNQ1OT1 Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test
Comprehensive Genetic Testing for Cancer Risk Assessment
The KCNQ1OT1 Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test represents a breakthrough in precision medicine for cancer risk assessment. This advanced diagnostic tool specifically analyzes the KCNQ1OT1 gene, which plays a critical role in regulating growth and development. Mutations in this gene are directly associated with Beckwith-Wiedemann syndrome, a rare genetic disorder characterized by overgrowth and significantly increased risk of developing childhood cancers.
What Does This Test Measure?
Our NGS-based genetic test provides comprehensive analysis of:
- Complete sequencing of the KCNQ1OT1 gene to identify pathogenic variants
- Detection of methylation abnormalities in the 11p15.5 chromosomal region
- Identification of genetic mutations linked to tumor predisposition
- Analysis of imprinting center defects associated with cancer risk
- Assessment of epigenetic modifications affecting gene expression
Who Should Consider This Test?
This genetic test is recommended for individuals exhibiting:
- Macroglossia (enlarged tongue) and abdominal wall defects
- Neonatal hypoglycemia and ear creases/pits
- Organomegaly (enlarged organs) and hemihypertrophy
- Family history of Beckwith-Wiedemann syndrome
- Personal history of embryonal tumors in childhood
- Unexplained overgrowth features or developmental abnormalities
- Suspected genetic predisposition to Wilms tumor or hepatoblastoma
Key Benefits of Genetic Testing
- Early Cancer Detection: Identify increased cancer risk before symptoms develop
- Personalized Surveillance: Create targeted cancer screening protocols
- Family Planning: Understand inheritance patterns for future generations
- Treatment Guidance: Inform medical management and intervention strategies
- Peace of Mind: Reduce uncertainty through definitive genetic information
Understanding Your Test Results
Your genetic test results will be thoroughly explained during your genetic counseling session. Possible outcomes include:
- Positive Result: Indicates the presence of a pathogenic variant requiring enhanced surveillance
- Negative Result: No detected mutations, though continued monitoring may be recommended
- Variant of Uncertain Significance: Requires additional family studies and ongoing research
- Methylation Abnormalities: Epigenetic changes that may require specialized management
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have branches across the United States, including major metropolitan areas such as New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, Milwaukee, Albuquerque, Tucson, Fresno, Sacramento, Mesa, Kansas City, Atlanta, Colorado Springs, Omaha, Raleigh, Miami, Long Beach, Virginia Beach, and Oakland.
Schedule Your Genetic Test Today
Take the first step toward understanding your genetic cancer risk. Our team of certified genetic counselors and oncology specialists are ready to provide comprehensive support throughout your testing journey. Contact us today to schedule your appointment and begin your path to personalized cancer prevention.
Call or WhatsApp: +1(267) 388-9828
Book your KCNQ1OT1 Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test now and take control of your health with advanced genetic insights.
